High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D MJW Sim, J Lu, M Spencer, F Hopkins, E Tran, SA Rosenberg, EO Long, ... Proceedings of the National Academy of Sciences 117 (23), 12826-12835, 2020 | 86 | 2020 |
Soluble urokinase plasminogen activator receptor (suPAR) independently predicts severity and length of hospitalisation in patients with COVID-19 H Enocsson, C Idoff, A Gustafsson, M Govender, F Hopkins, M Larsson, ... Frontiers in Medicine 8, 791716, 2021 | 35 | 2021 |
T cell perturbations persist for at least 6 months following hospitalization for COVID-19 M Govender, FR Hopkins, R Göransson, C Svanberg, EM Shankar, ... Frontiers in Immunology 13, 2022 | 24 | 2022 |
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19 FR Hopkins, M Govender, C Svanberg, J Nordgren, H Waller, ... Frontiers in Immunology 13, 7724, 2023 | 17 | 2023 |
The Native Orthobunyavirus Ribonucleoprotein Possesses a Helical Architecture FR Hopkins, B Álvarez-Rodríguez, GR Heath, K Panayi, S Hover, ... Mbio 13 (4), e01405-22, 2022 | 9 | 2022 |
Viral load at hospitalization is an independent predictor of severe COVID-19 H Waller, N Carmona Vicente, A James, M Govender, F Hopkins, ... European Journal of Clinical Investigation, 2023 | 5 | 2023 |
Pentameric C-reactive protein is a better prognostic biomarker and remains elevated for longer than monomeric CRP in hospitalized patients with COVID-19 FR Hopkins, J Nordgren, R Fernandez-Botran, H Enocsson, M Govender, ... Frontiers in Immunology 14, 1259005, 2023 | 1 | 2023 |
Altered DNA methylation pattern contributes to differential epigenetic immune signaling in the upper respiratory airway of COVID-19 patients M Govender, J Das, FR Hopkins, C Svanberg, J Nordgren, M Hagbom, ... bioRxiv, 2024.04. 29.591494, 2024 | | 2024 |
Ribonucleoprotein Structure in Pathogenic Orthobunyaviruses FR Hopkins University of Leeds, 2020 | | 2020 |